• Noctrix Health: Wearable Therapeutics For RLS

  • May 28 2024
  • Length: 39 mins
  • Podcast

Noctrix Health: Wearable Therapeutics For RLS

  • Summary

  • Host Mike Moore sits down with Shri Rhagunathan, President & CEO of Noctrix Health. Noctrix has the developed the only FDA approved device to Restless Legs Syndrome (RLS). This disease affects 1 in 10 Americans, and is the 2nd most common sleep disorder in the U.S. A limited number of pharmaceutical options currently exist to treat this disease state, all of which have a number of associated negative side effects. Their Nidra devices is a paradigm shifting breakthrough in a heavily under treated patient population.

    Resources & Links
    LinkedIn: Mike Moore
    LinkedIn: The Bleeding Edge of Digital Health

    Show More Show Less

What listeners say about Noctrix Health: Wearable Therapeutics For RLS

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.